The Marihuana Tax Act of 1937, Pub. L.Tooltip Public Law 75–238, 50 Stat. 551, enacted August 2, 1937, was a United States Act that placed a tax on the sale of cannabis. The H.R. 6385 act was drafted by Harry Anslinger and introduced by Rep. Robert L. Doughton of North Carolina, on April 14, 1937. The Seventy-fifth United States Congress held hearings on April 27, 28, 29th, 30th, and May 4, 1937. Upon the congressional hearings confirmation, the H.R. 6385 act was redrafted as H.R. 6906 and introduced with House Report 792. The Act is now commonly referred to, using the modern spelling, as the 1937 Marijuana Tax Act. This act was overturned in 1969 in Leary v. United States, and was repealed by Congress the next year.
Hitzig v Canada is a 2003 civil case that challenged the constitutionality of the Marihuana Medical Access Regulations (MMAR), now the Medical Marihuana Access Division. MMAR provided for exemptions from the law for approved medicinal users while allowing for no legal source of therapeutic cannabis products. The case was brought by Warren Hitzig, along with seven medical marijuana users.
In the United States, increased restrictions and labeling of cannabis as a poison began in many states from 1906 onward, and outright prohibitions began in the 1920s. By the mid-1930s cannabis was regulated as a drug in every state, including 35 states that adopted the Uniform State Narcotic Drug Act. The first national regulation was the Marihuana Tax Act of 1937.
Drug liberalization is a drug policy process of decriminalizing or legalizing the use or sale of prohibited drugs. Variations of drug liberalization include: drug legalization, drug re-legalization and drug decriminalization. Proponents of drug liberalization may favor a regulatory regime for the production, marketing, and distribution of some or all currently illegal drugs in a manner analogous to that for alcohol, caffeine and tobacco.
Cannabis in British Columbia (BC) relates to a number of legislative, legal, and cultural events surrounding the use and cultivation of cannabis in the Canadian province of British Columbia. As with the rest of Canada, cannabis became legalized on 17 October 2018, following the enactment of the Cannabis Act, or Bill C-45. Prior to that, though the drug was illegal in Canada, its recreational use was often tolerated and was more commonplace in the province of BC as compared to most of the rest of the country. The province's inexpensive hydroelectric power and abundance of water and sunshine—in addition to the many hills and forests —made it an ideal cannabis growing area. The British Columbia cannabis industry is worth an estimated CA$2 billion annually and produces 36.6 percent of all Canadian cannabis. The province is also the home of the cannabis activist and businessman Marc Emery.
A cannabis shop, cannabis dispensary, or cannabis cooperative, is a location at which cannabis is sold for recreational or medical use. In the Netherlands these are called coffeeshops. In the United States they exist as an outlet for both recreational and medical use. These shops differ from head shops in that the latter sells only drug paraphernalia. In 2015, the City of San Diego made A Green Alternative the first licensed medical cannabis dispensary and delivery service in the city. The world's largest cannabis dispensary is in Las Vegas, Nevada at 112,000 square feet opened by Planet 13 Holdings.
Cannabis in Michigan is legal for recreational use. A 2018 initiative to legalize recreational use passed with 56% of the vote. State-licensed sales of recreational cannabis began in December 2019.
Cannabis in Greece is illegal for recreational purposes. In 2017, the Greek government legalized the use of cannabis for medical purposes, and a year later, they lifted the ban on growing or producing it. This enables pharmaceutical companies to grow cannabis legally, and industrial hemp suppliers too.
The list includes and details significant events that occurred in the global history of national-level implementations of, or changes made to, laws surrounding the use, sale, or production of the psychoactive drug cannabis.
The Cannabis Act (C-45) of June, 2018 paved the way for the legalization of cannabis in Canada on 17 October 2018. Police and prosecution services in all Canadian jurisdictions are currently capable of pursuing criminal charges for cannabis marketing without a licence issued by Health Canada. The Supreme Court of Canada has held that the federal Parliament has the power to criminalize the possession of cannabis and that doing so does not infringe upon the Canadian Charter of Rights and Freedoms. The Ontario Court of Appeal and the Superior Court of Ontario have, however, held that the absence of a statutory provision for medical marijuana is unconstitutional, and to that extent the federal law is of no force and/or effect if a prescription is obtained. The recreational use of cannabis has been legalized by the federal government, and took effect on 17 October 2018.
Cannabis in Quebec became legal when the national Cannabis Act went into force on 17 October 2018. Cannabis in Canada has been legal for medicinal purposes since 2001 under conditions outlined in the Marihuana for Medical Purposes Regulations, later superseded by the Access to Cannabis for Medical Purposes Regulations, issued by Health Canada and seed, grain, and fibre production was permitted under licence by Health Canada.
On October 17, 2018, cannabis was legalized in Canada for recreational and medical purposes. It was already legal for medicinal purposes, under conditions outlined in the Marihuana for Medical Purposes Regulations issued by Health Canada, and for seed, grain, and fibre production under licence by Health Canada.
Cannabis in Prince Edward Island became legal when the national Cannabis Act went into force on October 17, 2018.
Cannabis has been legal in Nova Scotia and the entire country of Canada since October 17, 2018, the effective date of the Cannabis Act. Each province and territory set its own laws for various aspects, such as the legal age, whether householders can grow cannabis and the method of retail sales. Cannabis has been legal in Canada for medicinal purposes since 2001 under conditions outlined in the Marihuana for Medical Purposes Regulations, later superseded by the Access to Cannabis for Medical Purposes Regulations, issued by Health Canada and seed, grain, and fibre production was permitted under licence by Health Canada.
Cannabis in Newfoundland and Labrador became legal when the national Cannabis Act went into force on October 17, 2018.
Cannabis in Yukon became legal when the national Cannabis Act went into force on October 17, 2018.
Cannabis in Saskatchewan became legal when the national Cannabis Act went into force on 17 October 2018.
Cannabis in the Northwest Territories became legal when the national Cannabis Act went into force on 17 October 2018.
Cannabis in the Democratic Republic of the Congo is legal for industrial, medicinal and scientific use. It continues to be illegal for recreational use.
Tantalus Labs was a Canadian Licensed Producer of cannabis. Based out of British Columbia and established in 2012 by Dan Sutton, Tantalus Labs cultivated in their cannabis greenhouse, SunLab which was the first purpose-built cannabis greenhouse in North America. In June 2023, Tantalus Labs announced it would cease operations and began laying off the majority of its employees.
